Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Feb
14
2012
DOE Previews Significant Funding Opportunities for Offshore Wind McDermott Will & Emery
Jul
26
2012
Department of Interior Secretary Endorses Federal Regulation of Hydraulic Fracturing McDermott Will & Emery
Aug
24
2012
Federal Circuit Breathes Life Back Into DNA Patents McDermott Will & Emery
Apr
26
2013
Bipartisan Group of Legislators Reintroduces Master Limited Partnerships Parity Act McDermott Will & Emery
Mar
27
2018
ABI/SAB Miller Deal: DOJ Clarifies Best Efforts Clause in Proposed Final Judgment McDermott Will & Emery
Sep
26
2013
Opening the Floodgates for the Water Industry McDermott Will & Emery
Apr
1
2014
Exemptions for Energy Intensive Companies From Renewable Energy Surcharges: European Commission Opens In-Depth State Aid Investigation Against France McDermott Will & Emery
May
29
2014
Design Patents Go to the Dogs: District Court Not Required to Provide an Express Verbal Description of the Claimed Design McDermott Will & Emery
Jul
31
2014
A Compound Is Obvious Where Only Minor Changes to a Prior Art “Lead Compound” Are Required to Make the Claimed Compound McDermott Will & Emery
Feb
18
2022
McDermottPlus Check-Up: February 18, 2022 McDermott Will & Emery
Mar
25
2019
The Future of Direct Shipping McDermott Will & Emery
Sep
30
2014
The Doctrine of Obviousness-Type Double Patenting Maintains Its Vitality McDermott Will & Emery
May
1
2019
Foreign Investments In US Biotech Now Covered by CFIUS McDermott Will & Emery
Nov
20
2014
Health Resources and Services Administration (HRSA) Withdraws 340B Program Proposed Rule McDermott Will & Emery
May
24
2019
CDC and SAMHSA to Hold Summer Meetings for Public Health and Marijuana McDermott Will & Emery
Jun
27
2022
CMS Releases Cy 2023 End-Stage Renal Disease Prospective Payment System Proposed Rule McDermott Will & Emery
Jan
30
2015
Inherency Requires Factual Evidence that a Limitation Is Necessarily Present or Is the Natural Result McDermott Will & Emery
Mar
28
2015
Threshold Issues: IPR Not Derailed by Unidentified D/B/A Name or Prior ANDA Certification McDermott Will & Emery
Jul
1
2015
Activities For sNDA and Citizen’s Petition Protected by “Safe Harbor” - Supplemental New Drug Application McDermott Will & Emery
Sep
26
2019
SAFE Banking Act Passes House, Extends Cannabis Safe Harbor Protections McDermott Will & Emery
Oct
29
2015
Court Orders Re-Trial of AseraCare Falsity Phase Based on Jury Instruction Errors McDermott Will & Emery
Nov
25
2015
FDA Seeks Input on Uses of “Natural” in Food and Beverage Labeling McDermott Will & Emery
Dec
2
2015
A Substantially Pure Isomer Is Obvious When the Completely Pure Isomer Is Known In The Art: Spectrum Pharms., Inc. v. Sandoz Inc. McDermott Will & Emery
Feb
28
2023
This Week in 340B: February 21 – 27, 2023 McDermott Will & Emery
Dec
18
2015
Alcohol and Tobacco Tax and Trade Bureau Publishes List of Exempt Ingredients McDermott Will & Emery
Jan
8
2016
Ninth Circuit Opinion Calls into Question Constitutionality of California Tied-House Laws McDermott Will & Emery
Feb
17
2016
FCA Claims Based on Average Wholesale Price Theory Barred by Public Disclosure Bar McDermott Will & Emery
Mar
18
2016
Tied House Laws and Category Management: A Continuing Quandary McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins